Aptevo Therapeutics Inc (NASDAQ:APVO) Is 44.0% Above Its 52-Week Low, But Will It Continue To Rise?
Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares stood at 0.3 million during the latest session, with the company’s beta value hitting 5.14. At the last check